From Stage 4 to Remission: The Life-Altering Drug That Saved My Life

When Lalisha faced the devastating diagnosis of stage IV small cell lung cancer (SCLC), hope seemed elusive. The aggressive nature of the disease cast a shadow over their future. However, their determination led them to a transformative decision: to pursue alternative options for treatment. This choice culminated in the discovery of tarlatamab, recently showcased at the 2025 ASCO Annual Meeting. Months later, scans revealed no traces of cancer. Diagnosed in October 2023, Lalisha swiftly transitioned from a limited to extensive cancer stage, grappling with physical and emotional challenges. Frustrated by inadequate treatment at their initial facility, they bravely sought care at the Mayo Clinic, inspired by their mother’s tragic experience with healthcare shortcomings. After swift action, Lalisha received tarlatamab, witnessing significant health improvements. Now, a passionate advocate and support group facilitator, they emphasize the necessity for equitable access to innovative treatments, urging patients to take charge of their health journeys and advocate for themselves.